How do you approach treating thoracic disease in the setting of oligometastatic NSCLC in the era of immunotherapy/targeted agents?
Community PollStarted
How do you approach treating locally advanced thoracic disease in the setting of oligometastatic NSCLC?
6 physicians have voted
Join Mednetto vote and see how they answered.